Main

February 03, 2009

3Q RW 2008 Quality Report

This table presents results for the time period October - December 2008 (Ryan White B Third Quarter) of the HRSA/HAB Tier 1 Clinical Performance Measures. Please note there are many reasons for variation and the values posted. More information is posted below the table.

Service Outcome Measures CA DPCHC PU SAAF CTSS WMCPHD
Medical Visits: Percentage of (served) clients with HIV infection who had 2 or more medical visits in an HIV care setting in the measurement year. 83.7% 80.7% 60.0% 79.6% 56.0% 63.4%
CD4 T-cell count: Percentage of (served) clients with HIV infection who had 2 or more CD4 T-cell counts performed in the measurement year. 80.1% 80.7% 54.6% 65.3% 42.4% 49.3%
HAART: Percentage of (served) clients with AIDS who were prescribed HAART. 70.0% 64.6% 10.7% 93.1% 98.3% 90.5%
PCP Prophylaxis: Percentage of (served) clients with HIV infection and a CD4 T-cell count below 200 cells/mm who were prescribed PCP prophylaxis. 34.6% 24.7% 0.0% 66.7% 74.1% 7.7%
ARV Therapy For Pregnant Women: Percentage of (served) pregnant women with HIV infection who are prescribed antiretroviral therapy. 100% 22.2% N/A N/A N/A N/A

Many things might wildly affect your scores at this point: Bad or missing data in ARIES; Lack of consistency between agencies in how data is entered in ARIES. This is a baseline measurement and is intended for informational purposes. Comparisons between providers are not entirely possible because of limitations in data entry and differences in processes.

Posted by BVCOG-HIV at 09:24 AM |

2009 National Quality Center Technical Assistance (TA) Call Schedule

NQC has announced the schedule for the 2009 National TA Conference Calls. NQC hosts monthly National TA Calls on a variety of topics to highlight key quality improvement concepts and methodologies. Using webcasting technologies, participants can review the actual presentation slides and engage presenters in the Q&A session during the TA Call. Part-specific examples are provided and fellow grantees share their experiences and best practices.

2009 TA Call Schedule
- February 12, 3-4pm ET: Overview of Quality Improvement Learning Opportunities (new)
- March 12, 3-4pm ET: Effective Quality Improvement Meetings and Teams (new)
- April 9, 3-4pm ET: Writing and Updating Your Quality Management Plan
- May 14, 3-4pm ET: Developing a QM Action Plan (new)
- June 11, 3-4pm ET: Integrating HAB Core Measures Into your QM Program
- July 9, 3-4pm ET: Engaging Consumers in Quality Improvement
- August 13, 3-4pm ET: Quality Management for Case Managers and Non-Clinical Care (new)
- September 10, 3-4pm ET: Supporting Patient Self-Management
- October 8, 3-4pm ET: Improving Patient Retention
- November 12, 3-4pm ET: Health Literacy (new)
- December 10, 3-4pm ET: Lessons Learned from the Cross-Part Collaborative (new)

Participants must register for calls in advance. Registration for the calls opens several weeks before the call takes place. To learn more about the TA calls or to register, click here

Posted by BVCOG-HIV at 08:42 AM |

October 16, 2008

2Q RW 2008 Quality Report

This table presents results for the time period July - September 2008 (Ryan White B Second Quarter) of the HRSA/HAB Tier 1 Clinical Performance Measures. Please note, there are many reasons for variation and the values posted. More information is posted below the table.

Service Outcome Measures CA DPCHC PU SAAF CTSS WMCPHD
Medical Visits: Percentage of (served) clients with HIV infection who had 2 or more medical visits in an HIV care setting in the measurement year. 34.0% 25.1% 39.6% 81.8% 34.8% 51.9%
CD4 T-cell count: Percentage of (served) clients with HIV infection who had 2 or more CD4 T-cell counts performed in the measurement year. 73.9% 79.3% 46.9% 86.4% 54.5% 42.9%
HAART: Percentage of (served) clients with AIDS who were prescribed HAART. 88.9% 52.2% No data found 92.0% 98.0% 88.9%
PCP Prophylaxis: Percentage of (served) clients with HIV infection and a CD4 T-cell count below 200 cells/mm who were prescribed PCP prophylaxis. 22.2% 0.1% 15.3% 0.0% 8.5% 12.5%
ARV Therapy For Pregnant Women: Percentage of (served) pregnant women with HIV infection who are prescribed antiretroviral therapy. N/A 81.8% 100% N/A 33.3% N/A

Many things might wildly affect your scores at this point: Bad or missing data in ARIES; Lack of consistency between agencies in how data is entered in ARIES. This is a baseline measurement and is intended for informational purposes. Comparisons between providers are not entirely possible because of limitations in data entry and differences in processes.

Posted by BVCOG-HIV at 11:17 AM |